Back to search
FDAFDA · Food and drugs·Recall number D-0850-2020

Glycopyrrolate Tabs, USP, 1 mg, 30-count unit dose blister card, FOR INSTITUTIONAL USE ONLY, Rx Only, Packaged by Vangard, Glasgow, KY 42141; NDC 0615-8170-39.

Published February 26, 2020 · Recall initiated: January 28, 2020

Summary

FDA records drug Class II recall D-0850-2020, published February 26, 2020 and initiated January 28, 2020. Recalling firm: NCS Healthcare of Kentucky Inc; Status: Terminated; Reported quantity: 6929 blister cards; Lot: Lot #: 8170-9004, Exp 01/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specification: High Out of Specification Results for Individual Unknown Impurity.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
NCS Healthcare of Kentucky Inc
Distributor
Nationwide in the USA.
Lot
Lot #: 8170-9004, Exp 01/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Glycopyrrolate Tabs, USP, 1 mg, 30-count unit dose blister card, FOR INSTITUTIONAL USE ONLY, Rx Only, Packaged by Vangard, Glasgow, KY 42141; NDC 0615-8170-39. recalled?

Yes. FDA published recall D-0850-2020 on February 26, 2020. Reported hazard: Failed Impurities/Degradation Specification: High Out of Specification Results for Individual Unknown Impurity.

What should I do if I have this product?

Voluntary: Firm initiated · Letter